People who have a higher biological age than their actual chronological age have a significantly increased risk of stroke and dementia, especially vascular dementia.
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression | Psychedelic Invest
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided updates and guidance on